- Home
- SGRY vs RXRX Comparison
SGRY vs RXRX Comparison
Compare SGRY & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRY
- RXRX
- Stock Information
- Founded
- SGRY 2004
- RXRX 2013
- Country
- SGRY United States
- RXRX United States
- Employees
- SGRY N/A
- RXRX N/A
- Industry
- SGRY Hospital/Nursing Management
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SGRY Health Care
- RXRX Health Care
- Exchange
- SGRY Nasdaq
- RXRX Nasdaq
- Market Cap
- SGRY 2.8B
- RXRX 2.6B
- IPO Year
- SGRY 2015
- RXRX 2021
- Fundamental
- Price
- SGRY $22.79
- RXRX $4.46
- Analyst Decision
- SGRY Buy
- RXRX Buy
- Analyst Count
- SGRY 8
- RXRX 5
- Target Price
- SGRY $35.43
- RXRX $7.60
- AVG Volume (30 Days)
- SGRY 890.8K
- RXRX 23.1M
- Earning Date
- SGRY 05-12-2025
- RXRX 05-05-2025
- Dividend Yield
- SGRY N/A
- RXRX N/A
- EPS Growth
- SGRY N/A
- RXRX N/A
- EPS
- SGRY N/A
- RXRX N/A
- Revenue
- SGRY $3,114,300,000.00
- RXRX $59,790,000.00
- Revenue This Year
- SGRY $10.88
- RXRX $57.30
- Revenue Next Year
- SGRY $9.21
- RXRX $51.53
- P/E Ratio
- SGRY N/A
- RXRX N/A
- Revenue Growth
- SGRY 13.52
- RXRX 29.32
- 52 Week Low
- SGRY $19.50
- RXRX $3.79
- 52 Week High
- SGRY $33.97
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- SGRY 53.41
- RXRX 39.10
- Support Level
- SGRY $21.30
- RXRX $4.11
- Resistance Level
- SGRY $23.29
- RXRX $5.90
- Average True Range (ATR)
- SGRY 0.54
- RXRX 0.38
- MACD
- SGRY 0.22
- RXRX -0.10
- Stochastic Oscillator
- SGRY 73.76
- RXRX 20.25
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.